Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2021

View Archived Issues

Recombinant hemagglutinin-expressing HSV vector offers protection against both HSV and influenza

Compound inhibits acute myeloid leukemia cells with FLT3-ITD mutations by targeting HSP70

Aston University descibres new antibacterials

New antivirals presented by EcoSynth, Transmare Chemie

Leiden University and collaborators patent monoglyceride lipase inhibitors

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

APMAP identified as a regulator of cancer cell phagocytosis

Kynurenine metabolites as biomarkers of chronic fatigue syndrome and fibromyalgia

Primate model of autism spectrum disorder reveals potential therapeutic targets

Identification of novel viral cleavage sites and potential therapeutic targets against SARS-CoV-2

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Different way of looking allows new insights into cancer biology

Elastase inhibition enhances the adjuvant activity of alum for SARS-CoV-2 vaccination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...